Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion type Assertion NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_head.
- NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion description "[Areas of progress include valid and repeatable methods of disease definition, global documentation of disease prevalence and impact, clarification of the role of some genetic factors, such as filaggrin gene mutations, clear evidence that environmental factors are key, as demonstrated by the positive social class gradient and rising prevalence, a possible protective effect of infections in early life, documentation of comorbidities, such as a reduced risk of glioma, and mapping the evidence base through systematic reviews and an online global resource of clinical trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_provenance.
- NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion evidence source_evidence_literature NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_provenance.
- NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion SIO_000772 23331673 NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_provenance.
- NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion wasDerivedFrom befree-20140225 NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_provenance.
- NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_assertion wasGeneratedBy ECO_0000203 NP896821.RAAiDb3CpS1_UtGnAp7UxBl9LrI7Qx046dm3cnHrZ93l0130_provenance.